# Salveo Capital

> Salveo Capital is a VC fund in Chicago backing Cannabis and Agriculture. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Chicago, United States
- Total investments: 16
- Last investment: Nov 2021
- Lead investor: 13%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/salveo-capital
- X (Twitter): https://twitter.com/salveocapital
- Website: http://www.salveocapital.com/

Salveo Capital is a private investment fund that partners with leading entrepreneurs and management teams to build high-scaling successful companies within the legalized cannabis eco-system.Salveo is predominately focused on the ancillary sectors of the market, which include: software and data; financial payments and services; ag-tech and yieldimprovement technologies; biotech and pharma; and licensing and branding.

## Contacts

5 contacts available for Salveo Capital. Shizune tracks 5 team members at Salveo Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/salveo-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.5M–$3M |
| Series A | $3.5M–$24M |
| Series B | $7.5M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cannabis | 5 | 31% |
| Agriculture | 4 | 25% |
| Farming | 2 | 13% |
| Health Care | 2 | 13% |
| Biotechnology | 2 | 13% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 31% |
| Series B | 3 | 19% |
| Seed | 2 | 13% |
| Series C | 1 | 6% |
| Funding Round | 1 | 6% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michael Gruber | Managing Partner | 10 | https://shizune.co/investors/profile/michael-gruber |
| Jeff Howard | Managing Partner | 0 | https://shizune.co/investors/profile/jeff-howard |
| John Dohm | Co-Founder & Partner | 0 | https://shizune.co/investors/profile/john-dohm-59c3 |
| Sean Doyle | Principal | 0 | https://shizune.co/investors/profile/sean-doyle-3ab2 |
| Thomas Mazarakis | Managing Partner & Advisory Board Member | 0 | https://shizune.co/investors/profile/thomas-mazarakis |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Semasio (formerly Fyllo) | Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. | $40M | Series C | Nov 08, 2021 |  |
| Wurk | Wurk is the leader in HR, Payroll, and Payment technology servicing the fastest-growing emerging industry, cannabis! Wurk's proprietary Compliant Payment Cloud underwriters cannabis businesses enabling them to process payments for payroll, taxes, 401k, benefits, and more positioning Wurk as the largest payments processor in the industry. TheirSaaS HCM Cloud provides Modern HR, Payroll, Time & Attendance, Scheduling accessible on any device, including tablets and mobile. Wurk's Intralytics Cloud (integration meets analytics) connects the industries leading technology providers allowing operators to combine and analyze data to inform mission-critical decisions. Wurk is also assembling this data to provide industry benchmarks to help operators compare their KPIs to the trends of the industry. Wurk's unique platform is proving that Human Capital Management, Workforce Management, and Payment technology providers can add significant value to their customers by focusing on their vertical-specific needs.Wurk was founded in August 2015 by Keegan Peterson. And it is headquartered in Denver, Colorado. | $3.5M | Series A | Apr 22, 2021 |  |
| Semasio (formerly Fyllo) | Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. | $30M | Series B | Apr 06, 2021 |  |
| Coda Signature | Coda Signature is an award winning infused products company based in Colorado. | $6M | Venture - Series Unknown | Feb 01, 2021 |  |
| Semasio (formerly Fyllo) | Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. | $10M | Series A | Aug 12, 2020 |  |
| Equilibria | Equilibria sells CBD gels, oils and creams specifically for women that are designed to help with anxiety, sleep and menstrual cramp relief. | $2M | Seed | Apr 27, 2020 |  |
| Front Range Biosciences | Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $18.7M | Series B | Feb 14, 2020 |  |
| Front Range Biosciences | Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $18.7M | Series B | Feb 14, 2020 |  |
| PathogenDx | PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M | Series B | Sep 30, 2019 |  |
| Front Range Biosciences | Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $8.5M | Series B | Sep 16, 2019 |  |

10 of 16 investments shown.

## Co-investors
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund, 6 deals together
- [Sand Hill Angels](https://shizune.co/investors/profile/sand-hill-angels) — VC Fund, 6 deals together
- [HALLEY Venture Partners](https://shizune.co/investors/profile/halley-venture-partners) — VC Fund, 5 deals together
- [New York Angels](https://shizune.co/investors/profile/new-york-angels) — VC Fund, 4 deals together
- [AFI Capital Partners](https://shizune.co/investors/profile/afi-capital-partners) — VC Fund, 3 deals together
- [Gotham Green Partners](https://shizune.co/investors/profile/gotham-green-partners) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Casa Verde Capital](https://shizune.co/investors/profile/casa-verde-capital) — VC Fund
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Cannabis Investors](https://shizune.co/investors/cannabis-investors)
- [Cannabis VC Funds](https://shizune.co/investors/cannabis-vc-funds)
- [Cannabis Investors in United States](https://shizune.co/investors/cannabis-investors-united-states)
- [Cannabis VC Funds in United States](https://shizune.co/investors/cannabis-vc-funds-united-states)

## FAQ

### What does Salveo Capital invest in?

Salveo Capital invests primarily in Cannabis, Agriculture and Farming startups, most often at Series A and Series B stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Salveo Capital's check size?

Salveo Capital typically joins rounds of $1.5M–$3M at Seed, $3.5M–$24M at Series A and $7.5M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Salveo Capital participates in.

### How do I contact Salveo Capital?

Public channels for Salveo Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Salveo Capital?

The team at Salveo Capital includes Michael Gruber (Managing Partner), Jeff Howard (Managing Partner) and John Dohm (Co-Founder & Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co